Coca‑Cola reported fourth‑quarter 2025 revenue of $11.82 billion, a 2% year‑over‑year increase that fell short of the $12.05 billion consensus by $0.23 billion. The shortfall was driven largely by weaker demand for its flagship Coca‑Cola sodas in North America, where sales were dampened by shifting health preferences and the growing use of GLP‑1 weight‑loss drugs, as well as adverse currency movements that eroded revenue in other regions.
Adjusted earnings per share rose to $0.58, beating the $0.56 consensus by $0.02 or 3.6%. The beat was largely a result of disciplined cost management, lower interest expense, and tax savings, while the company’s pricing power in concentrate sales helped offset the volume decline. The 1% rise in unit case volume and a 5% increase in organic revenue—driven by a 4% lift in concentrate sales and a 1% gain in price/mix—supported the earnings performance.
Segment analysis shows North America revenue grew 5.6% year‑over‑year, while Asia Pacific revenue fell 6.3% year‑over‑year. Concentrate sales increased 4%, and price/mix gains contributed 1% to organic revenue growth. Unit case volume grew 1% for the quarter. Operating margin contracted to 15.6% from 23.5% in the prior year, largely due to a $960 million non‑cash impairment charge related to the BODYARMOR trademark and currency headwinds that pressured margins.
Management guided for 2026 organic revenue growth of 4%–5% and comparable earnings‑per‑share growth of 7%–8%. CEO James Quincey described the outlook as “realistic, but prudent,” citing confidence in pricing power but acknowledging the challenging consumer environment. The guidance reflects a cautious stance amid weaker demand and the need to maintain margin discipline while investing in portfolio transformation.
Market reaction was negative: shares fell 1.56% at $76.74, following a 3.8% drop in pre‑market trading. Investors focused on the revenue miss and the conservative 2026 guidance, which signaled a potential slowdown in top‑line momentum despite the EPS beat. The reaction underscored concerns about the company’s ability to sustain growth in a shifting consumer landscape.
Implications for investors are mixed. The EPS beat demonstrates effective cost control and pricing power, but the revenue miss and margin compression highlight headwinds that could limit growth. Management’s emphasis on cost discipline and portfolio transformation, coupled with the upcoming CEO transition to Henrique Braun, suggests a strategic focus on long‑term resilience while navigating short‑term market challenges.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.